A single-centre prospective randomised controlled trial of the effect of reduced doses of inhaled glucocorticoids on the risk of acute exacerbation of stable COPD

Liu Shuxiang; An Yongpeng; Yang Xiuzhi

doi:10.3969/j.issn.1002-1949.2023.07.007

Home>Articles>A single-centre prospective randomised controlled trial of the effect of reduced doses of inhaled glucocorticoids on the risk of acute exacerbation of stable COPD

DOI: 10.3969/j.issn.1002-1949.2023.07.007

A single-centre prospective randomised controlled trial of the effect of reduced doses of inhaled glucocorticoids on the risk of acute exacerbation of stable COPD

Liu Shuxiang

An Yongpeng

Yang Xiuzhi

Keywords：Inhaled glucocorticoidThioredoxin binding protein/Nod-like receptor protein 3(TXNIP/NLRP3)Lung functionBody mass indexobstructiondyspneaexercise(BODE)indexChronic obstructive pulmonary disease(COPD)

Publication Date：2023-07-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 545-550 )

Chinese Journal of Critical Care Medicine

ISTIC

ISSN：1002-1949

Year, Vol.(Issue)：2023,43(7)